The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome

Clinical Medicine: Cardiology

Volumn 2009, Issue 3, 2009, Pages 29-36

  Garadah, Taysir S ^a,b   Kassab, Salah ^a   Al Shboul, Qasim M ^a   Alawadi, Abdulhai ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b NONE   (Bahrain)

Author keywords

Acute myocardial infarction; Glycosylated hemoglobin; Stress hyperglycemia

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DATA ANALYSIS; DATA EXTRACTION; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; PATIENT CODING; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 65449139123     PISSN: None     EISSN: 11781165     Source Type: Journal    
DOI: 10.4137/cmc.s2289     Document Type: Article

References (32)

1. Schneider CA, Gahwitz B, Hanefeld M, Muller-Wieland D, Zeymer U, Erdmann E. Hyperglycemia and cardiovascular events. Dtsch Med Chenschr. 2004;(47):2553-7.
2. Blok V, Cornel JH, Arnold AE, Scpress J, Umans VA. Impaired glucose metabolism predicts mortality after myocardial infarction. Int J Cardiol. 2001;79(23):207-14.
3. Ceriello A. Acute hyperglycemia: a new risk factor during myocardial infarction. Eur Heart J. 2005;26(4):328-31.
4. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;(6):754-60.
5. Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR. Diabetes and stress hyperglycemia associated with myocardial infarction at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev. 2005;13(5):223-30.
6. Cubbon RM, Wheateroft SB, Grant PJ, Gale CP, Barth JH, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Euro Heart J. 2007;28(5):540-5.
7. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, et al. Prognostic value of admission plasm glucose and HBA in acute myocardial infarction. Diabet Med. 2005;21(4);305-10.
8. Gustafosson I, Kistorp CN, Jaes MK, Faber JO, Dickstein K, Hildebrandt PR (OPTIMAAL Study group). Unrecognized glycometabolic disturbance as measured by hemoglobin A1C is associated with a poor outcome after acute myocardial infarction. Am Heart J. 2007;154(3):470-6.
9. Third report of the National Cholesterol Education Program (NECP) Expert Panel on detection, evaluation, and treatment of the high blood cholesterol in adult (adult treatment panel III) Circulation. 106:3143.
10. Wahab NN, Cowden EA, Pearce NJ, Merry H, Cox JL (ICONS Investigator). Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? Int J Cardiol. 2002;20:40(10):1748-54.
11. Boik J, Van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Am heart J. 2001;79(2-3):207-17.
12. Stranders I, Diamant M, Van Gelder RE, Spruijt Twisk JW, Heine I, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;10:164(9):982-8.
13. Irma AL, Akman D, Bruun NE, Kober L, Brendorp B, Ottesen M, et al. Importance of a history for the prognosis after acute myocardial infarction: for the bucindolol evaluation in acute myocardial infarction (BEAT) study group. Clinical Cardiology. 2004;27:265-269.
14. Lindblad U, Rastam L, Rantam J. Acute myocardial infarction in patients treated for hypertension in Skaraborg hypertension Project. European heart Journal. 1993;14:291-296.
15. Timmer JR, Vander Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, De Boer MJ, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am heart J. 2004;148(3) 399-404.
16. Peturson O, Herlitz J, Caidahl K, et al. Admission Glycemia and outcome after acute coronary syndrome. Int J Cardiol. 2007;116(3):315-20.
17. Timmer JR, Ottervanger JP, Bilo HP, et al. Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM. 2006;99(4):237-43.
18. Cubbon RM, Rajwaani A, Abbas A, et al. Hyperglycemia in relation to sex and mortality after acute coronary syndrome. Eur J cardiovasc Prev rehabil. 2007;14(5):666-71.
19. Schneider CA, Gallwitz B, Hanefeld M, et al. Hyperglycemia and Cardiovascular events. Dtsch Med wochenschr. 2004;19;129 (47):2553-7.
20. Wong VW, Ross DL, Park K, Boyages SC, Cheung NW. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res. Clin. Pract. 2004;64(2):85-91.
21. Meisinger C. Admission blood glucose and adverse outcome in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol. 2005;13:238-241.
22. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes Diabet. Med. 2005;22(10):1321-5.
23. Capes SE, Hunt D, Malmberg K, Cerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patient with and without diabetes: a systemic review. Lancet. 2000;4(355):773-8.
24. Oswald GA, Smith CC, Delamothe AP, Betteridge DJ, Yudkin JS: Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J. 1988;59:663-671.
25. Del Valle HF, Lascano EC, Negroni JA. Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial LATP channels. Cardiovasc Res. 2002;55(3);642-59.
26. Undas A, Wiek I, Stepien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes care. 2008;31(8):1590-5.
27. Devos P, Chiolero R, Van den Berghe G, Preiser JC. Glucose, insulin and myocardial ischaemia. Curr opin Clin Nutr Metab Care. 2007;(2):206-9.
28. Miles PD, Romeo OM, Higo K, Cohen A, Rafft K, Olefesky JM. TNF-α-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes. 1997;46:1678-1683.
29. Das UN. Insulin: an endogenous cardio-protector. Current Opin Crit Care. 2003;9(5):375-83.
30. Chowdhury TA, Lasker SS. Elevated glycosylated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J. 1998;74(874):480-1.
31. Hansen EB, Larsson CA, Gulberg B, Melander A, Bostorom K, et al. Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care, A population-based follow up study in the Skaraborg project. Scandinavian Journal of Primary Health Care. 2007;25:237-243.
32. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body Mass Index, a risk factor for unstable angina and myocardial infarction in patients with angiographically Confirmed Coronary Artery Disease. Circulation. 2003;108:2206-16.